RHAG and hepatocellular carcinoma: Collectively, these diverse findings shed light on the multifaceted mechanisms by which Rh2 exerts its therapeutic effects via lncRNAs in numerous cancers, such as breast cancer and hepatocellular carcinoma, as well as in various human diseases, including bone formation and even corneal health.